Published in Int J Alzheimers Dis on March 01, 2017
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A (1986) 9.31
Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging (1997) 7.54
Perfusion imaging. Magn Reson Med (1992) 7.40
Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A (1992) 6.83
A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med (1998) 4.38
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Alzheimer's disease and angiogenesis. Lancet (2003) 4.19
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med (2014) 3.27
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab (1999) 2.98
Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology (2009) 2.70
Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol (2000) 2.35
Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology (2007) 2.09
Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol (1999) 1.94
The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study. Neuroimage (2009) 1.92
Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging (2008) 1.82
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr (1983) 1.77
Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol (2008) 1.71
Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy (2005) 1.67
Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab (2007) 1.50
Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage (2008) 1.49
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49
Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling. Magn Reson Med (1995) 1.48
Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis (2010) 1.48
Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology (2012) 1.38
Intra- and multicenter reproducibility of pulsed, continuous and pseudo-continuous arterial spin labeling methods for measuring cerebral perfusion. J Cereb Blood Flow Metab (2011) 1.31
Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab (1998) 1.29
Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging (2006) 1.26
Comparative overview of brain perfusion imaging techniques. J Neuroradiol (2005) 1.24
NMR measurement of perfusion using arterial spin labeling without saturation of macromolecular spins. Magn Reson Med (1995) 1.21
Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology (1996) 1.15
Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord (2009) 1.14
Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis (2011) 1.13
Reduced susceptibility effects in perfusion fMRI with single-shot spin-echo EPI acquisitions at 1.5 Tesla. Magn Reson Imaging (2004) 1.11
Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol (2009) 1.09
Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis (2003) 1.07
Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging. J Cereb Blood Flow Metab (2014) 1.05
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis (2011) 1.05
Angiogenic signaling in Alzheimer's disease. Neuroreport (2004) 1.05
Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna) (2009) 1.03
Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease. Eur Radiol (2009) 1.03
Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. J Histochem Cytochem (1991) 1.01
Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis (2006) 1.00
Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Res (2000) 0.96
Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology (2014) 0.92
Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med (1998) 0.92
Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol (2010) 0.92
In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease. Angiogenesis (2006) 0.91
Beta amyloid angiogenic activity in vitro and in vivo. Int J Mol Med (2007) 0.91
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia. Hum Brain Mapp (2014) 0.87
Nonlinearity correction of brain perfusion SPECT based on permeability-surface area product model. J Nucl Med (1996) 0.86
Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease. J Neuroimaging (2015) 0.85
Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J Alzheimers Dis (2012) 0.85
Multi-vendor reliability of arterial spin labeling perfusion MRI using a near-identical sequence: implications for multi-center studies. Neuroimage (2015) 0.84
Advances in perfusion magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement (2010) 0.84
Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Clin Interv Aging (2014) 0.80
Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease. Alzheimers Dement (2014) 0.79
Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling. Magn Reson Imaging (2015) 0.79
SPECT imaging in dementias. J Nucl Med (2001) 0.78
Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Neurodegener Dis (2015) 0.75